---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-109258"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2023-04-21T23:59:59+00:00"
generated_at: "2026-06-16T21:57:41.113170+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q1 EPS $4.85 beats prior year; raises 2023 revenue and profit guidance

## Summary
- Q1 revenues $15.591B (up 4.3% YoY); net income $1.363B, diluted EPS $4.85 vs $4.14.
- Adjusted EBITDA $3.172B vs $2.944B; same facility admissions +4.4%, equivalent admissions +7.5%.
- Board declared $0.60/share dividend payable June 30, 2023, record June 16.
- Repurchased 3.34M shares for $846M in Q1; $3.74B remaining under authorization.
- 2023 guidance raised: revenue $62.5-64.5B; EPS $17.25-18.55; Adjusted EBITDA $12.1-12.7B.

## SEC filing metadata
- accession: 0001193125-23-109258
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2023-04-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/d431466d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-109258
- JSON: https://secwatch.observer/filing/0001193125-23-109258.json
- Plain text: https://secwatch.observer/filing/0001193125-23-109258.txt

## Key facts
- Earnings Releases
  HCA Healthcare, Inc. reported first quarter ended March 31, 2023 results: revenue $15.591 billion, net income $1.363 billion, EPS $4.85 per diluted share.
  - Period: first quarter ended March 31, 2023
  - Revenue: $15.591 billion
  - Net income: $1.363 billion
  - EPS: $4.85 per diluted share
  - Result: reported results
  source text: Revenues in the first quarter of 2023 increased to $15.591 billion, compared to $14.945 billion in the first quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.363 billion, or $4.85 per diluted share, compared to $1.273 billion, or $4.14 per diluted share, in the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm
- Earnings Releases
  HCA Healthcare, Inc. reported Full year 2023 results: revenue $62.5 to $64.5 billion, net income $4.750 to $5.160 billion, EPS $17.25 to $18.55 per diluted share. Guidance raised.
  - Period: Full year 2023
  - Revenue: $62.5 to $64.5 billion
  - Net income: $4.750 to $5.160 billion
  - EPS: $17.25 to $18.55 per diluted share
  - Guidance: raised
  - Result: guidance update
  source text: The 2023 guidance ranges for the year have been revised from our fourth quarter release as follows: Previous 2023 Guidance Range as of January 27, 2023 2023 Guidance Range as of April 21, 2023 Revenues $61.5 to 63.5 billion $62.5 to $64.5 billion Net Income Attributable to HCA Healthcare, Inc. $4.525 to $4.895 billion $4.750 to $5.160 billion Adjusted EBITDA $11.8 to $12.4 billion $12.1 to $12.7 billion EPS (diluted) $16.40 to $17.60 per diluted share $17.25 to $18.55 per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.